inTest Q2 Results: Sales guidance raised to $35.000M vs $33.013M est

scanx
Reviewed by
Riya DScanX News Team
Key Highlights

inTest upgrades Q2 preliminary sales guidance to $35.000 million, beating the $32.000 million-$34.000 million range and $33.013 million estimate. The revision highlights strong operational performance ahead of final results.

powered bylight_fuzz_icon
47047922

*this image is generated using AI for illustrative purposes only.

inTest (AMEX: INTT) has raised its preliminary sales guidance for the second quarter to $35.000 million, exceeding market expectations of $33.013 million. This upward revision signals stronger-than-anticipated demand or operational performance during the period, as the new figure sits above the company’s prior guidance range of $32.000 million to $34.000 million.

The adjustment reflects a positive deviation from both internal forecasts and external analyst consensus. By lifting the top end of its previous range by $1.000 million, inTest indicates robust underlying business momentum heading into the finalization of its quarterly results.

Guidance Revision Details

The following table outlines the changes in inTest’s sales outlook:

Metric Value
Previous Guidance Range $32.000 million - $34.000 million
Analyst Estimate $33.013 million
Revised Preliminary Sales $35.000 million

What the Numbers Show

The revision represents a clear beat against consensus estimates. With the revised figure of $35.000 million, inTest is now projecting sales approximately $1.987 million higher than the estimated $33.013 million. This suggests that operational execution has outpaced initial projections, potentially driven by stronger order intake or accelerated revenue recognition during the quarter.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

Which specific product lines or geographic regions are driving the unexpected surge in Q2 demand for inTest?

Will inTest raise its full-year revenue guidance to reflect this stronger-than-anticipated Q2 performance?

How might this beat against consensus estimates impact inTest's stock valuation and short-term trading volume?

like15
dislike

InTest raises FY26 sales guidance to $135-140M vs $133.9M estimate

scanx
Reviewed by
Naman SScanX News Team
Key Highlights

InTest Corporation raised its full-year 2026 revenue guidance to $135-140 million, exceeding the $133.911 million estimate, driven by strong Q2 revenue of $35 million. Despite the top-line beat, gross margins missed expectations at ~40% due to operational issues at Alfamation and supply chain disruptions, leading to a revised full-year margin outlook of ~43%.

powered bylight_fuzz_icon
47046798

*this image is generated using AI for illustrative purposes only.

InTest Corporation (NYSE: INTT) raised its full-year 2026 revenue guidance to a range of $135 million to $140 million, surpassing the market estimate of $133.911 million. The upward revision follows a strong second quarter where preliminary revenue reached approximately $35 million, beating the prior guidance range of $32 million to $34 million. This top-line performance was driven by strengthening demand across key end markets including Semiconductor, Automotive/EV, and Defense/Aerospace. Despite the revenue beat, gross margin fell short at approximately 40%, missing the guided ~45% target due to operational headwinds at its Alfamation subsidiary.

The margin shortfall of approximately 500 basis points was attributed to two primary factors. First, lower-than-expected delivered gross margin on projects shipped by Alfamation accounted for approximately 340 basis points of the miss, driven by an unfavorable project mix. Second, a supply chain disruption delayed the shipping of approximately $2 million of ITS revenue into the third quarter, negatively impacting volume for the Environmental Technologies segment and accounting for the remaining 160 basis points. Operating expenses were estimated at $13.9 million, within the guided range of $13.8 million to $14.2 million.

Revision of First Quarter Financial Statements

InTest announced it will revise its first quarter 2026 financial results to correct an overstatement of gross margin caused by implementation issues with a new ERP system at Alfamation. Management determined that first quarter total consolidated gross profit was overstated by approximately $750,000, equating to a 220-basis point downward revision to previously reported Q1 gross margin. While the company stated this accounting error was not material for the quarter ended March 31, 2026, correcting the cumulative effect is material to current-period results. Consequently, InTest expects to report a material weakness in its internal control over financial reporting, though management believes the weakness has been remediated.

Revised Full Year Outlook

Reflecting year-to-date performance and anticipated order activity, InTest raised its full-year 2026 revenue guidance from $130 million to $135 million to the new range of $135 million to $140 million. However, full-year gross margin guidance was lowered to approximately 43%, down from 45%, due to reductions in Alfamation’s margins for the first half partially offset by an expected improved mix in the second half. Other full-year metrics remain unchanged: operating expenses are guided at $55 million to $57 million, amortization expense at $2.6 million, interest expense at $0.3 million, and capital expenditures at approximately 1% to 2% of revenue. The effective tax rate is expected to remain at approximately 18%.

What the Numbers Show

The data reveals a clear bifurcation between top-line momentum and bottom-line execution. While demand strength allowed InTest to exceed revenue targets and beat analyst estimates, the inability to capture expected margins at Alfamation suggests that volume growth alone does not guarantee profitability improvement. The ERP-related accounting error further underscores operational risks in integrating acquired entities, as evidenced by the need for a material weakness disclosure. Investors should monitor whether the projected "improved mix" in H2 can sufficiently offset the H1 margin drag to achieve the revised 43% annual target.

Metric Q2 2026 Preliminary Q2 2026 Guidance Variance
Revenue $35 million $32 million - $34 million Above Range
Gross Margin ~40% ~45% -500 bps
Operating Expenses $13.9 million $13.8 million - $14.2 million Within Range

Management will discuss these results and corporate strategy on a conference call scheduled for Monday, August 10, 2026, at 8:30 a.m. ET. Duncan Gilmour, Chief Financial Officer, noted disappointment regarding the delayed realization of the Alfamation margin overstatement, while President and CEO Rich Rogoff emphasized that instilling operational discipline remains his top priority.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific operational changes is InTest implementing at Alfamation to ensure the projected H2 margin improvement materializes?

How will the disclosed material weakness in internal controls impact InTest's audit processes and investor confidence in future financial reporting?

Is the supply chain disruption affecting ITS revenue a temporary logistical issue or indicative of broader structural vulnerabilities in the Environmental Technologies segment?

like17
dislike

More News on Intest